Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Medical Marijuana programs: Implications for cannabis control policy – Observations from Canada
Benedikt Fischer, Sharan Kuganesan, Robin Room
International Journal of Drug Policy (2014) Vol. 26, Iss. 1, pp. 15-19
Closed Access | Times Cited: 84

Showing 1-25 of 84 citing articles:

Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013
Deborah S. Hasin, Tulshi D. Saha, Bradley T. Kerridge, et al.
JAMA Psychiatry (2015) Vol. 72, Iss. 12, pp. 1235-1235
Open Access | Times Cited: 996
Medical marijuana laws and adolescent marijuana use in the USA from 1991 to 2014: results from annual, repeated cross-sectional surveys
Deborah S. Hasin, Melanie M. Wall, Katherine M. Keyes, et al.
The Lancet Psychiatry (2015) Vol. 2, Iss. 7, pp. 601-608
Open Access | Times Cited: 259
Medical Marijuana and Marijuana Legalization
Rosalie Liccardo Pacula, Rosanna Smart
Annual Review of Clinical Psychology (2017) Vol. 13, Iss. 1, pp. 397-419
Open Access | Times Cited: 249
The implementation and public health impacts of cannabis legalization in Canada: a systematic review
Wayne Hall, Daniel Stjepanović, Danielle Dawson, et al.
Addiction (2023) Vol. 118, Iss. 11, pp. 2062-2072
Open Access | Times Cited: 44
Changes in Incident Schizophrenia Diagnoses Associated With Cannabis Use Disorder After Cannabis Legalization
Daniel T. Myran, Michael Pugliese, Lyndsay D. Harrison, et al.
JAMA Network Open (2025) Vol. 8, Iss. 2, pp. e2457868-e2457868
Open Access | Times Cited: 3
Race, cannabis and the Canadian war on drugs: An examination of cannabis arrest data by race in five cities
Akwasi Owusu‐Bempah, Alex Luscombe
International Journal of Drug Policy (2020) Vol. 91, pp. 102937-102937
Closed Access | Times Cited: 80
Changes in Cannabis-Attributable Hospitalizations Following Nonmedical Cannabis Legalization in Canada
Daniel T. Myran, Adrienne Gaudreault, Lauren Konikoff, et al.
JAMA Network Open (2023) Vol. 6, Iss. 10, pp. e2336113-e2336113
Open Access | Times Cited: 24
Association between non-medical cannabis legalization and emergency department visits for cannabis-induced psychosis
Daniel T. Myran, Michael Pugliese, Rhiannon Roberts, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 10, pp. 4251-4260
Closed Access | Times Cited: 23
Is cannabis an illicit drug or a medicine? A quantitative framing analysis of Israeli newspaper coverage
Sharon R. Sznitman, Nehama Lewis
International Journal of Drug Policy (2015) Vol. 26, Iss. 5, pp. 446-452
Closed Access | Times Cited: 65
Federalism, partial prohibition, and cross-border sales: Evidence from recreational marijuana
Benjamin Hansen, Keaton Miller, Caroline Weber
Journal of Public Economics (2020) Vol. 187, pp. 104159-104159
Open Access | Times Cited: 64
Exploring the use of cannabis as a substitute for prescription drugs in a convenience sample
Sinikka L. Kvamme, Michael Mulbjerg Pedersen, Kristine Rømer Thomsen, et al.
Harm Reduction Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 41
Cannabis legalization with strict regulation, the overall superior policy option for public health
Jürgen Rehm, Benedikt Fischer
Clinical Pharmacology & Therapeutics (2015) Vol. 97, Iss. 6, pp. 541-544
Closed Access | Times Cited: 64
The Psychiatric Consequences of Cannabinoids
João P. De Aquino, Mohamed Sherif, Rajiv Radhakrishnan, et al.
Clinical Therapeutics (2018) Vol. 40, Iss. 9, pp. 1448-1456
Open Access | Times Cited: 58
Normalization and denormalization in different legal contexts: Comparing cannabis and tobacco
Mark Asbridge, Jenna Valleriani, Judith Kwok, et al.
Drugs Education Prevention and Policy (2016) Vol. 23, Iss. 3, pp. 212-223
Closed Access | Times Cited: 53
Making medicine; producing pleasure: A critical examination of medicinal cannabis policy and law in Victoria, Australia
Kari Lancaster, Kate Seear, Alison Ritter
International Journal of Drug Policy (2017) Vol. 49, pp. 117-125
Closed Access | Times Cited: 50
Medical Cannabis Use Among Older Adults in Canada: Self-Reported Data on Types and Amount Used, and Perceived Effects
Shankar Tumati, Krista L. Lanctôt, RuoDing Wang, et al.
Drugs & Aging (2021) Vol. 39, Iss. 2, pp. 153-163
Open Access | Times Cited: 40
Cannabis for Medical Use: Analysis of Recent Clinical Trials in View of Current Legislation
Francesca Baratta, Irene Pignata, Lorenzo Ravetto Enri, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 26
Illicit drug use and harms, and related interventions and policy in Canada: A narrative review of select key indicators and developments since 2000
Benedikt Fischer, Yoko Murphy, Katherine Rudzinski, et al.
International Journal of Drug Policy (2015) Vol. 27, pp. 23-35
Closed Access | Times Cited: 45
Articulating addiction in alcohol and other drug policy: A multiverse of habits
Suzanne Fraser
International Journal of Drug Policy (2015) Vol. 31, pp. 6-14
Open Access | Times Cited: 42
Medical cannabis for chronic pain: can it make a difference in pain management?
Mari Kannan Maharajan, Yu Jing Yong, Hong Yang Yip, et al.
Journal of Anesthesia (2019) Vol. 34, Iss. 1, pp. 95-103
Closed Access | Times Cited: 39
Facing the option for the legalisation of cannabis use and supply in New Zealand: An overview of relevant evidence, concepts and considerations
Benedikt Fischer, Dimitri Daldegan‐Bueno, Joseph M. Boden
Drug and Alcohol Review (2020) Vol. 39, Iss. 5, pp. 555-567
Open Access | Times Cited: 36
A systematic review of medical students’ and professionals’ attitudes and knowledge regarding medical cannabis
Jared Weisman, Marcus Rodríguez
Journal of Cannabis Research (2021) Vol. 3, Iss. 1
Open Access | Times Cited: 29
The adverse public health effects of non-medical cannabis legalisation in Canada and the USA
Tesfa Mekonen Yimer, Eva Hoch, Benedikt Fischer, et al.
The Lancet Public Health (2025) Vol. 10, Iss. 2, pp. e148-e159
Open Access
Engagement with medical cannabis information from online and mass media sources: Is it related to medical cannabis attitudes and support for legalization?
Nehama Lewis, Sharon R. Sznitman
International Journal of Drug Policy (2019) Vol. 73, pp. 219-227
Closed Access | Times Cited: 34
Perceived support for medical cannabis use among approved medical cannabis users in Canada
Cesar Leos‐Toro, Samantha Shiplo, David Hammond
Drug and Alcohol Review (2018) Vol. 37, Iss. 5, pp. 627-636
Closed Access | Times Cited: 33
Page 1 - Next Page

Scroll to top